A detailed history of Lipe & Dalton transactions in Moderna, Inc. stock. As of the latest transaction made, Lipe & Dalton holds 8,147 shares of MRNA stock, worth $300,216. This represents 0.27% of its overall portfolio holdings.

Number of Shares
8,147
Previous 9,842 17.22%
Holding current value
$300,216
Previous $1.17 Million 53.46%
% of portfolio
0.27%
Previous 0.63%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$63.64 - $125.14 $107,869 - $212,112
-1,695 Reduced 17.22%
8,147 $544,000
Q2 2024

Aug 02, 2024

SELL
$101.21 - $166.61 $66,292 - $109,129
-655 Reduced 6.24%
9,842 $1.17 Million
Q1 2024

May 07, 2024

SELL
$85.37 - $115.44 $329,955 - $446,175
-3,865 Reduced 26.91%
10,497 $1.12 Million
Q2 2023

Jul 26, 2023

SELL
$118.5 - $160.53 $592 - $802
-5 Reduced 0.03%
14,362 $1.75 Million
Q1 2023

May 02, 2023

SELL
$135.66 - $197.02 $37,577 - $54,574
-277 Reduced 1.89%
14,367 $2.21 Million
Q4 2022

Feb 03, 2023

BUY
$118.38 - $210.04 $1.73 Million - $3.08 Million
14,644 New
14,644 $2.63 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Lipe & Dalton Portfolio

Follow Lipe & Dalton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.